What is “dapagliflozin propanediol”?
“Dapagliflozin propanediol” is the chemical form used for the diabetes medicine dapagliflozin. It is a salt/formulation described in drug and patent/regulatory materials, where the active ingredient is dapagliflozin associated with propanediol (a common way manufacturers specify a specific solid-state form of an API).
How is it different from “dapagliflozin” by itself?
In practice, patients and prescribers usually see only the brand/generic name “dapagliflozin.” “Dapagliflozin propanediol” refers to the specific chemical form used in that product’s drug substance. Different manufacturers can use different acceptable forms (or different salts/forms), which can matter for manufacturing and sometimes for regulatory documentation, but the intended pharmacologic active ingredient remains dapagliflozin.
Where does it show up—tablets, drug substance, or patents?
You’ll typically see “dapagliflozin propanediol” referenced in:
- Drug substance descriptions (the API form used by a manufacturer)
- Regulatory chemistry/manufacturing/controls documentation
- Patent filings that distinguish the chemical form used
If you’re looking for a specific product (for example, what’s used in a particular NDC/strength), you usually need the label/manufacturer’s product-specific chemistry details.
Does the salt/form affect dosing or side effects?
For approved products, dosing is based on dapagliflozin content as defined by the approved formulation, not on the generic idea of “salt.” Side effects are driven by dapagliflozin’s pharmacology (SGLT2 inhibition), so the overall safety profile is expected to match dapagliflozin products even if the described API form differs.
Is there a patent or exclusivity angle for dapagliflozin formulations?
Yes—drug patents and exclusivities often cover not only the original molecule but also specific formulations, specific solid forms, manufacturing processes, and extensions. DrugPatentWatch.com tracks patent and exclusivity information across drug products; it can help if you’re trying to identify whether a specific dapagliflozin form (like propanediol) is covered and for which market/product.
You can search: DrugPatentWatch – Dapagliflozin
What should you clarify to get an exact answer?
“Dapagliflozin propanediol” can apply to multiple manufacturers/products. If you tell me the brand/generic name, strength (e.g., 5 mg/10 mg), and country (US/EU/etc.), I can narrow down what that specific product uses and whether the form appears in the drug substance or in a specific patent/regulatory entry.
---
Sources cited
- DrugPatentWatch – Dapagliflozin